Announcements Trials
Browse Landscape

Status

Recruiting 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 34Observational 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Breast Neoplasms 24Carcinoma, Non-Small-Cell Lung 15Colorectal Neoplasms 13Neoplasms 12Lung Neoplasms 12Stomach Neoplasms 9Neoplasm Metastasis 6Colonic Neoplasms 6Esophageal Neoplasms 5Small Cell Lung Carcinoma 4Pancreatic Neoplasms 4Leukemia, Myeloid, Acute 4Head and Neck Neoplasms 4Esophageal Squamous Cell Carcinoma 4Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma 3Ovarian Neoplasms 3Osteosarcoma 3Multiple Myeloma 3Melanoma 3Lymphoma, Follicular 3Lymphoma 3Waldenstrom Macroglobulinemia 2Vulvar Neoplasms 2Uterine Cervical Neoplasms 2Thymus Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Rectal Neoplasms 2

Interventions

Drug Therapy 4Positron Emission Tomography Computed Tomography 2Nivolumab 2Magnetic Resonance Imaging 2Immunohistochemistry 2Diffusion Magnetic Resonance Imaging 2Blood Specimen Collection 2Biopsy 2Tomography, X-Ray Computed 1Surgical Procedures, Operative 1Radiotherapy 1Polymerase Chain Reaction 1Neoadjuvant Therapy 1Mass Spectrometry 1Lymph Node Excision 1In Situ Hybridization, Fluorescence 1Immunotherapy 1Immune Checkpoint Inhibitors 1Gastroscopy 1Fluorouracil 1Esophagectomy 1Endoscopy 1Dynamic Contrast Enhanced Magnetic Resonance Imaging 1Cisplatin 1Base Sequence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Esophageal Squamous Cell Carcinoma × Drug Therapy × Clear all
NCT06504615 2026-04-03

METAGIO

Bristol-Myers Squibb

Active not recruiting
208 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Adenocarcinoma

NCT06710665 2024-11-29

Tumor Regression Grade As Predictor of Adjuvant Therapy

Fujian Medical University Union Hospital

Recruiting
400 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05740995 2023-03-21

Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Shanghai Zhongshan Hospital

Recruiting
40 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05028231 2021-08-31

NICCE

Tongji Hospital

Unknown
46 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡